Cargando…

Promising Immunotherapeutic Modalities for B-Cell Lymphoproliferative Disorders

Over the last few years, treatment principles have been changed towards more targeted therapy for many B-cell lymphoma subtypes and in chronic lymphocytic leukemia (CLL). Immunotherapeutic modalities, namely monoclonal antibodies (mAbs), bispecific antibodies (bsAbs), antibody-drug conjugates (ADCs)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mihályová, Jana, Hradská, Katarína, Jelínek, Tomáš, Motais, Benjamin, Celichowski, Piotr, Hájek, Roman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584080/ https://www.ncbi.nlm.nih.gov/pubmed/34768899 http://dx.doi.org/10.3390/ijms222111470

Ejemplares similares

Management of Treatment-Related Infectious Complications in High-Risk Hemato-Oncological Patients via Telemedicine
por: Hradská, Katarína, et al.
Publicado: (2022)

Toxicity of Immune-Checkpoint Inhibitors in Hematological Malignancies
por: Hradska, Katarina, et al.
Publicado: (2021)

Natural Killer Cells in the Malignant Niche of Multiple Myeloma
por: Venglar, Ondrej, et al.
Publicado: (2022)

A Bird’s-Eye View of Cell Sources for Cell-Based Therapies in Blood Cancers
por: Motais, Benjamin, et al.
Publicado: (2020)

The Benefit of Telemonitoring in the Prevention of Septic Shock in a Patient with Aggressive Non-Hodgkin’s Lymphoma
por: Dudová, Lucie, et al.
Publicado: (2023)

Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility
por: Celichowski, Piotr, et al.
Publicado: (2023)

Emerging Immunotherapeutic and Diagnostic Modalities in Carcinoid Tumors
por: Vellani, Shahnaz D., et al.
Publicado: (2023)

Fc Receptor-Like 1 as a Promising Target for Immunotherapeutic Interventions of B-Cell-Related Disorders
por: Yousefi, Zahra, et al.
Publicado: (2019)

An economic evaluation of the effectiveness of telemedicine in hematooncology
por: Lebiedzik, Marian, et al.
Publicado: (2023)

Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment
por: Motais, Benjamin, et al.
Publicado: (2021)

Posttransplant Lymphoproliferative Disorders
por: Ibrahim, Hazem A. H., et al.
Publicado: (2012)

Treg: A Promising Immunotherapeutic Target in Oral Diseases
por: Zhang, Yujing, et al.
Publicado: (2021)

Update on PD-1/PD-L1 Inhibitors in Multiple Myeloma
por: Jelinek, Tomas, et al.
Publicado: (2018)

Tumor-Infiltrating B Lymphocytes: Promising Immunotherapeutic Targets for Primary Liver Cancer Treatment
por: Milardi, Giulia, et al.
Publicado: (2023)

Oncolytic Virotherapy as Emerging Immunotherapeutic Modality: Potential of Parvovirus H-1
por: Moehler, Markus, et al.
Publicado: (2014)

Oral Lesions and Lymphoproliferative Disorders
por: Castellarin, P., et al.
Publicado: (2010)

JAK-STAT in lymphoproliferative disorders
por: Rabadan, Raul, et al.
Publicado: (2015)

Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders
por: Pospiskova, Jana, et al.
Publicado: (2019)

T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?
por: Zhou, Qi, et al.
Publicado: (2020)

Mutational and immunogenetic landscape of HCV‐associated B‐cell lymphoproliferative disorders
por: Defrancesco, Irene, et al.
Publicado: (2021)

The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders
por: Al-Zubaidi, Hanaan Kareem, et al.
Publicado: (2023)

New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders
por: Quintanilla-Martinez, Leticia, et al.
Publicado: (2022)

Case Report: Composite Angioimmunoblastic T-Cell Lymphoma and Epstein-Barr Virus-Positive B-Cell Lymphoproliferative Disorder as Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders
por: Kakiuchi, Seiji, et al.
Publicado: (2020)

Somatic changes in B-lymphoproliferative disorders (B-LPD) detected by DNA-fingerprinting.
por: de Jong, D., et al.
Publicado: (1988)

Novel Local “Off-the-Shelf” Immunotherapy for the Treatment of Myeloma Bone Disease
por: Charvátová, Sandra, et al.
Publicado: (2023)

Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing
por: Xue, Qianqian, et al.
Publicado: (2023)

X‐linked lymphoproliferative syndrome associated with Epstein–Barr virus encephalitis and lymphoproliferative disorder
por: Mukai, Takeo, et al.
Publicado: (2023)

LTX-315 – a promising novel antitumor peptide and immunotherapeutic agent
por: Zweytick, Dagmar
Publicado: (2019)

SLAMF7 as a Promising Immunotherapeutic Target in Multiple Myeloma Treatments
por: Chu, Emily, et al.
Publicado: (2023)

Immunomodulatory activity of manganese dioxide nanoparticles: Promising for novel vaccines and immunotherapeutics
por: Huang, Yuhe, et al.
Publicado: (2023)

Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders
por: Crombie, Jennifer L., et al.
Publicado: (2019)

Epstein-Barr Virus Positive B-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract
por: Ishikawa, Eri, et al.
Publicado: (2021)

KRAS and RAS-MAPK Pathway Deregulation in Mature B Cell Lymphoproliferative Disorders
por: Vendramini, Elena, et al.
Publicado: (2022)

Clinicopathological features and individualized treatment of kidney involvement in B-cell lymphoproliferative disorder
por: Nie, Guangyan, et al.
Publicado: (2022)

Uncommon Presentation of Undiagnosed B-Cell Lymphoproliferative Disorder as Nodular Pulmonary Amyloidosis
por: Patel, Harsh, et al.
Publicado: (2023)

Ocular post-transplant lymphoproliferative disorder
por: Chen, Yun-Wen, et al.
Publicado: (2015)

Human Herpesvirus 8 and Lymphoproliferative Disorders
por: Calabrò, Maria Luisa, et al.
Publicado: (2018)

EP33 Sjögren’s and lymphoproliferative disorders
por: Yein, Khin, et al.
Publicado: (2020)

Cardiovascular Disease, Lymphoproliferative Disorders, and Thymomas
por: Huston, Sharon M., et al.
Publicado: (2012)

Management of post-transplant lymphoproliferative disorders
por: Dierickx, Daan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_99msrjlv9jarqhg8caqbc7g6vo